Upgrade to SI Premium - Free Trial

CVS Health's (CVS) Signify Health Deal to 'Bolster Health Services Business Growth' - Mizuho

September 6, 2022 12:35 PM
Mizuho Securities analyst Ann Hynes reiterated a Buy rating and $120.00 price target on CVS Health (NYSE: CVS), saying the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles